Applied Genetic Technologies (AGTC) Misses Q2 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. CVS
9. SPY
10. XYZ

Go back to Applied Genetic Technologies (AGTC) Misses Q2 EPS by 1c

AGTC Announces Financial Results and Business Update for the Quarter Ended December 31, 2020

February 11, 2021 7:00 AM EST

- Company on track to provide multiple data readouts for XLRP and ACHM clinical programs in 2021 and 2022 -

- Net proceeds of approximately $69.2 million from a recent public offering provide cash runway into calendar year 2023 -

- Company to host conference call and webcast today at 8:00 a.m. ET -

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for... More